The global contract research organization Worldwide Clinical Trials is making an acquisition of Catalyst Clinical Research.

Expansion will increase production volume and scale manufacturing capacity for next-gen drugs for metabolic conditions.

GSK has agreed to acquire RAPT Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing novel ...

Borealis AG will invest €49 million to expand production of advanced polypropylene grades at its manufacturing site in ...

Alteogen and Tesaro, a subsidiary of GSK, have entered an exclusive license agreement concerning a subcutaneous formulation of dostarlimab.

AstraZeneca will buy AbelZeta Pharma’s 50% share of development and commercialization rights in China for a CAR-T therapy for ...

Harbour BioMed announced its wholly owned subsidiary is exercising a warrant agreement to acquire common stock in Spruce ...

suitable for safely storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and ...

Syngene International, a global CRDMO, has extended its long-standing strategic collaboration with Bristol Myers Squibb ...

Qosina has released its New Product Preview, showcasing more than 500 newly added components designed to help engineers solve ...

Apiject Holdings Inc. has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...